Flagship Harbor Advisors, LLC Inovio Pharmaceuticals, Inc. Transaction History

Flagship Harbor Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$8.5 - $12.85 $3,187 - $4,818	-375 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$9.57 - $27.05 $2,966 - $8,385	310 Added 476.92%	375 $4,000
Q2 2020 Jul 31, 2020	SELL	$7.14 - $31.69 $3,284 - $14,577	-460 Reduced 87.62%	65 $1,000
Q1 2020 May 12, 2020	BUY	$2.98 - $14.09 $1,490 - $7,045	500 Added 2000.0%	525 $4,000
Q3 2019 Oct 22, 2019	SELL	$2.05 - $3.02 $1,025 - $1,510	-500 Reduced 95.24%	25 $0
Q2 2019 Jul 22, 2019	BUY	$2.29 - $4.1 $1,145 - $2,050	500 Added 2000.0%	525 $1,000
Q2 2018 Aug 14, 2018	BUY	$3.88 - $5.16 $97 - $129	25 New	25 $0

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $499M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.